Cabometyx

Exelixis lands PhIII kidney cancer win with Bristol Myers in their hunt for $4 billion
Endpoints
Mon, 04/20/20 - 11:59 pm
Bristol-Myers Squibb
Opdivo
Exelixis
Cabometyx
renal cell carcinoma
kidney cancer
clinical trials
Exelixis Reports Positive Results in Metastatic Castration-Resistant Prostate Cancer Study
Motley Fool
Wed, 02/12/20 - 10:27 am
Exelixis
prostate cancer
metastatic castration-resistant prostate cancer
cabozantinib
Cabometyx
Exelixis Bolsters Pipeline in Deal with India's Aurigene
BioSpace
Fri, 08/2/19 - 12:20 am
Exelixis
Indian
Aurigene
Cabometyx
After a long march with Cabo, Exelixis is expanding its focus with an antibody-drug conjugate deal
Endpoints
Thu, 05/16/19 - 10:25 am
Exelixis
Cabometyx
ICON-2
Iconic Therapeutics
antibody-drug conjugate
Exelixis initiates phase 3 trial of cabozantinib in advanced renal cell carcinoma
Pharmaceutical Business Review
Thu, 05/2/19 - 11:20 am
Exelixis
clinical trials
cabozantinib
Cabometyx
advanced renal cell carcinoma
Exelixis Proves Being Second Can Work Out Well
Motley Fool
Wed, 02/13/19 - 05:04 pm
Exelixis
Bristol-Myers Squibb
Cabometyx
kidney cancer
FDA approves Cabometyx for liver cancer
BioCentury
Mon, 01/14/19 - 11:59 pm
Exelixis
Ipsen
Cabometyx
liver cancer
FDA
Exelixis Grabs Its Share of the Kidney-Cancer Treatment Market
Motley Fool
Tue, 11/6/18 - 09:34 am
Exelixis
earnings
kidney cancer
Cabometyx
Why Merck's Latest Success Means Trouble for Exelixis Inc.
Yahoo/Motley Fool
Fri, 10/19/18 - 09:13 am
Merck
Exelixis
Cabometyx
Keytruda
Exelixis Begins Ph III Trial of Cabometyx in Refractory Thyroid Cancer
CP Wire
Mon, 10/8/18 - 09:55 am
Exelixis
Cabometyx
thyroid cancer
Exelixis Begins Ph III Trial of Cabometyx in Refractory Thyroid Cancer
Mon, 10/8/18 - 09:25 am
Exelixis
Cabometyx
thyroid cancer
Exelixis and Ipsen Announce Positive CHMP Opinion for Cabometyx in Previously Treated Hepatocellular Carcinoma
CP WIre
Fri, 09/21/18 - 10:02 am
Exelixis
Ipsen
Cabometyx
hepatocellular carcinoma
Exelixis and Ipsen Announce Positive CHMP Opinion for Cabometyx in Previously Treated Hepatocellular Carcinoma
Fri, 09/21/18 - 10:01 am
Exelixis
Ipsen
Cabometyx
hepatocellular carcinoma
Canada Approves Cabometyx for Adults with Previously Treated Advanced Renal Cell Carcinoma
CP Wire
Wed, 09/19/18 - 11:27 am
Exelixis
Cabometyx
Takeda
Canada
Japan
Ipsen
renal cell carcinoma
Canada Approves Cabometyx for Adults with Previously Treated Advanced Renal Cell Carcinoma
Wed, 09/19/18 - 09:16 am
Exelixis
Ipsen
Cabometyx
National Comprehensive Cancer Network Releases New Guidelines for Cabometyx for Advanced Renal Cell Carcinoma
CP Wire
Fri, 09/7/18 - 11:05 am
Exelixis
Cabometyx
advanced renal cell carcinoma
National Comprehensive Cancer Network Releases New Guidelines for Cabometyx for Advanced Renal Cell Carcinoma
Fri, 09/7/18 - 09:44 am
Exelixis
Cabometyx
advanced renal cell carcinoma
Exelixis Gets the Patients Eventually
Motley Fool
Mon, 08/6/18 - 11:47 pm
Exelixis
kidney cancer
renal cell carcinoma
Cabometyx
Exelixis Expands Ph Ib Immunotherapy Trial to Include Additional Patients with Locally Advanced or Metastatic Solid Tumors
CP Wire
Fri, 06/1/18 - 09:55 am
Exelixis
clinical trials
Cabometyx
Tecentriq
Exelixis Expands Ph Ib Immunotherapy Trial to Include Additional Patients with Locally Advanced or Metastatic Solid Tumors
Fri, 06/1/18 - 09:37 am
Exelixis
Cabometyx
Tecentriq

Pages